2,6-Dichloro-5-fluoronicotinamide, 95.0%, 25g

ethyl cyclopropyl(oxo)acetate, 95.0%, 100mg

N-(3-(Dimethylamino)propyl)tetradecanamide, 95.0%, 5g

Anthracene, >=96%, for synthesis, 100 g, plastic packaging.

[4-morpholin-4-yl-3-(morpholin-4-ylsulfonyl)phenyl]amine, 5g

(S)-2-Amino-3-methoxypropanoic acid, 95.0%, 10g

4-((tert-Butoxycarbonyl)(methyl)amino)benzoic acid, 95.0%, 1g

2-amino-5-methyl-4-(4-methylphenyl)thiophene-3-carboxamide, 95.0%, 5g

3-Phenyl-pentan-3-ol, 97.0%, 1g

(5-Hydroxy-2-(trifluoromethoxy)phenyl)boronic acid, 98%, 10g

1H-Spiro[furo[3,4-c]pyridine-3,4'-piperidin]-1-one hydrochloride, 95.0%, 250mg

Methyl 3-methoxy-4-(trifluoromethoxy)benzoate, 95%, 250mg

1-Methyl-4-(1,4'-bipiperidin-4-yl)piperazine, 95%, 1g